City of Hope’s Linda Malkas, Ph.D., Appointed to State’s Stem Cell Agency Board

DUARTE, Calif.–(BUSINESS WIRE)–Linda
Malkas
, Ph.D., deputy director of basic research for City of Hope
who holds the M.T. & B.A. Ahmadinia Professorship in Molecular Oncology,
has been appointed to the governing board of the California
Institute for Regenerative Medicine
(CIRM), the state’s Stem Cell
Agency.

California Treasurer John Chiang made the appointment, saying: “She has
had a stellar career in both research and administration, promoting and
advancing research in women’s health with a particular focus on breast
cancer. Dr. Malkas’ research expertise is in the areas of human cell DNA
replication/repair, in biomarker and therapeutic target discovery and
development.

“Dr. Malkas is extraordinarily well-qualified for the post. Her résumé
certainly reflects that. She was the founding director of the Indiana
Center for Breast Cancer Research. She discovered a molecule that can
inhibit certain activities in cancerous cells and hopes to move that
into clinical trials in the near future,” Chiang added. “She served for
five years on a National Cancer Institute (NCI) subcommittee reviewing
cancer center designations. She has served as chair on several NCI study
panels and recently took on an advisory role on drug approval policy
with the Food and Drug Administration.”

Malkas said she is honored by the opportunity to serve California
through CIRM’s board.

“The research and technologies developed through this agency have
benefited the health of not only Californians but the nation and world
itself,” she added. “I am excited to see what the future holds for the
work of this agency.”

In addition to her leadership role at City of Hope, Malkas is a
professor of molecular and cellular biology at Beckman Research
Institute of City of Hope and joint head of the Molecular Oncology
Program.

Malkas earned her master’s and doctorate degrees from City University of
New York. She has published more than 75 peer-reviewed articles in
medical journals and, in her spare time, is a member of the editorial
boards for the journals Cancer Research, Cancer Prevention
Research
, Current Cancer Therapy Reviews and the American
Journal of Translational Research
.

“We are extremely happy to welcome Dr. Malkas to the Board,” said
Jonathan Thomas, Ph.D., J.D., chair of the CIRM board. “Not only has she
demonstrated expertise and leadership in science and academia, but the
collaborative approach she has shown throughout her career make her an
excellent addition to CIRM.”

In her spare time, Malkas enjoys spending time at her ranch with her
family and friends. She also enjoys riding her four horses, and taking
care of her dogs and cats. She is a lover of the sci-fi genre and enjoys
“Star Trek” and vintage sci-fi movies, as well as “Harry Potter” books
and films.

About City of Hope

City of Hope is an independent research and treatment center for cancer,
diabetes and other life-threatening diseases. Designated as one of only
47 comprehensive cancer centers, the highest recognition bestowed by the
National Cancer Institute, City of Hope is also a founding member of the
National Comprehensive Cancer Network, with research and treatment
protocols that advance care throughout the world. City of Hope is
located in Duarte, California, just northeast of Los Angeles, with community clinics
throughout Southern California. It is ranked as one of “America’s Best
Hospitals” in cancer by U.S. News & World Report. Founded in
1913, City of Hope is a pioneer in the fields of bone marrow transplantation,
diabetes
and numerous
breakthrough cancer drugs
based on technology developed at the
institution. For more information about City
of Hope
, follow us on Facebook,
Twitter,
YouTube
or Instagram.

Contacts

City of Hope
Letisia Marquez
626-218-3398
lemarquez@coh.org